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HEPAT 01260 
Azygos and hepatic extraction of atrial natriuretic factor (ANF) in 
patients with cirrhosis 
No evidence of reduced disposal 
Atrial natriuretic factor (ANF) ils a circulating hor- 
mone with natriuretic and vasodilating effects, which 
has been reported to be decreased, normal or elevated 
in different patients with cirrhosis. Thus, Hollister et al. 
(I) and Moreau et al. (2) have suggested that decreased 
splanchnic removal plays a role in the abnormal evels 
of ANF  reported in some patients with cirrhosis. 
Recently, we found a normal hepato-enteric clearance in 
patients with cirrhosis (274+46 vs 237+46 ml/min in 
controls, n.s.) (3). As pointed out then, our results only 
accounted for disposal from those parts of the liver and 
intestine that are drained through the hepatic veins (2). 
Oesophageal varices are drained through the azygos 
vein. However, the extraction of ANF  in blood drained 
through this vein has hitherto not been investigated. 
The present investigation was therefore undertaken to 
determine azygos extraction of ANF  in patients with 
cirrhosis. 
We report results from 9 patients (age 52-68, mean 
58 years) with biopsy-verified cirrhosis (8 alcoholic, 1 
posthepatitic), who underwent hepatic and azygos vein 
catheterization. Fluid retention and ascites were present 
in 7 patients. Patients without fluid retention were not 
restricted as to diet, whereas those with ascites were put 
on a sodium diet of 40 mmol/day. Seven patients received 
diuretics. Six patients with minor disorders and 
unrestricted iet served as controls. Catheterization pro- 
cedure, flow measurements, assessment of extraction and 
clearance, and analysis of ANF  have been described in 
detail elsewhere (3-5). 
The mean arterial concentration of ANF  in the 
patients was similar to that of the controls (10.0 +1.4 vs. 
9.6+2.8pmol/1, respectively, n.s.). As illustrated in 
Figure 1, a substantial arterio-azygos extraction 
(0.35+0.09) was present in patients with cirrhosis and 
directly correlated to the arterio-hepatic extraction 
(0.33+0.10, r=0.86, p<0.005). Azygos and hepato- 
enteric clearances of ANF  were similar (Table 1) and the 
TABLE 1 
Splanchnic disposal of atrial natriuretic factor (ANFI in patients with cirrhosis and controls 
Azygos blood Hepatic blood EAN F EANF Azygos ANF 
flow flow Azygos Hepatic clearance 
(l/min) (I/min) (ml/min) 
Hepatoenteric 
ANF 
clearance 
(ml/min) 
Overall 
splanchnic 
ANF 
clearance 
(ml/min) 
Overall 
splanchnic 
ANF 
removal 
(pmol/min) 
Cirrhosis 0.97 1.29 0.35 0.33 235 
(n=9) +0.09 +0.09 +0.09 +0.097 +75 
Controls I. I0 0.53 33 b 
(n = 6) + 0.17 + 0.09 
320 
+146 
347 
+81 
552 a 
__+91 
380 
+90 
5.8 
+1.8 
3.3 
+0.5 
Mean + SEM. EAt~l: = arterial-venous extraction ratio of ANF. 
'p=0.1. 
h Estimated from a normal azygos blood flow f 0.15 l/min and an extraction ratio of 0.5. 
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overall splanchnic learance and removal of ANF  were 
similar or slightly higher in the patients compared to 
controls. We did not find any significant relation between 
ANF extraction, clearance or removal rate, on the one 
hand, and S-bilirubin (r=0.18-0.37), S-albumin (1"= 
-0 .43  to -0.48)  or hepatic venous pressure gradient 
( r=-0 .42  to -0.62),  on the other. 
Plasma levels of ANF  in our cirrhotic patients were 
similar to those in the control subjects. This may be due 
to the fact that control subjects were studied on an 
unrestricted diet and most patients were studied on 
dietary sodium restriction and while being treated with 
diuretics (which are known to decrease ANF  levels). This 
resulted in comparable arterial ANF  in the two groups. 
The present study shows substantial and similar 
extraction of ANF  in the azygos and hepato-enteric 
venous beds in patients with cirrhosis. Thus, a major 
part of the splanchnic inflow of ANF  is cleared through 
the superior collateral flow. This shows conclusively that 
the overall splanchnic removal of ANF  is not decreased 
in patients with cirrhosis as Hollister et al. have suggested 
(1). In fact, the overall splanchnic removal of ANF  
tended to be somewhat higher in the patients than in 
the controls. 
ANF  is rapidly hydrolyzed by endopeptidase 24.11 
and cleared by specific receptors identified in most 
vascular endothelial cells. The high ANF  extraction in 
azygos plasma, as found in the present study, is similar 
to extraction described in other tissues (1,2). Our finding, 
therefore, may suggest hat the degradation of ANF  in 
blood drained through the axygos venus bed is mediated 
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Fig. 1. Relationship between arterial-azygos venous (E^Nv. azygo,) and 
arterial-hepatic venous (EASE. h~) extraction ratio of ANF in 9 patients 
with cirrhosis (r = 0.86, p < 0.005; y = 0.83x + 0.07). 
by the same mechanisms (i.e. related to vascular struc- 
tures) as those described for other tissues. 
Jens H. Henriksen, Fiemming Bendtsen and Alexander 
L. Gerbes 
Departments of Clinical Physiology and Hepatology, Hvidovre Hospital, 
University of Copenhagen, Copenhagen, Denmark. t, d Department of
hzternal Medicine II, Klinikum Grosshadern, Ludwig Maximilian Univer- 
sity, Munich, Germany. 
References  
I Hollister AS, Rodeheffer R J, White FJ et al. Clearance of atrial 
natriuretic factor by lung, liver, and kidney in human subjects and 
the dog. J Clin Invest 1989; 83: 623-8. 
2 Moreau R, Pussord E, Brenard R, Goudin C, Berdeaux A, Lebrec D. 
Clearance of atrial natriuretic peptide in patients with cirrhosis. 
Role of liver failure. J Hepatol 1991; 13: 351-7. 
3 Henriksen JH, Bendtsen F, Schiitten H J, Warberg J. Hepat ic -  
intestinal disposal of endogenous human alpha atrial natriuretic 
factor 99-126 in patients with cirrhosis. Am J Gastroentroenterol 
1990; 85:1155-9. 
4 Henriksen JH, Bendtsen F, Gerbes AL. Splanchnic removal of 
human alpha-atrial natriuretic p ptide in humans: enhancement 
after food intake. Metabolism 1990; 39: 553-6. 
5 Gerbes AL, Wernze H, Arendt RM et al. Atrial natriuretic factor 
(ANF) and renin-aldosterone in volume regulation of p e ts with 
cirrhosis. Hepatology 1989; 9: 417-22. 
